Adma Biologics (ADMA) Research & Development (2016 - 2025)
Historic Research & Development for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to $1.5 million.
- Adma Biologics' Research & Development rose 27087.38% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 10214.13%. This contributed to the annual value of $1.8 million for FY2024, which is 4506.06% down from last year.
- Latest data reveals that Adma Biologics reported Research & Development of $1.5 million as of Q3 2025, which was up 27087.38% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Adma Biologics' Research & Development ranged from a high of $1.5 million in Q3 2025 and a low of $391000.0 during Q4 2024
- For the 5-year period, Adma Biologics' Research & Development averaged around $829368.4, with its median value being $826000.0 (2025).
- In the last 5 years, Adma Biologics' Research & Development tumbled by 6008.55% in 2024 and then surged by 27087.38% in 2025.
- Adma Biologics' Research & Development (Quarter) stood at $728928.0 in 2021, then surged by 47.42% to $1.1 million in 2022, then tumbled by 58.49% to $446000.0 in 2023, then dropped by 12.33% to $391000.0 in 2024, then soared by 290.79% to $1.5 million in 2025.
- Its Research & Development stands at $1.5 million for Q3 2025, versus $1.0 million for Q2 2025 and $826000.0 for Q1 2025.